Targeting the gut-liver axis in cholangiocarcinoma: mechanisms, therapeutic advances, and future directions
{{output}}
Cholangiocarcinoma (CCA), a highly aggressive biliary tract malignancy, exhibits rising incidence rates and an extremely poor prognosis. Recent studies reveal that gut-liver axis dysregulation drives CCA progression through gut microbiota dysbiosis, bile acid ... ...
